Chemcrux Enterprises has announced a board meeting outcome revealing several key strategic decisions.

The company approved its financial results for the quarter, following review by the Audit Committee.

The board also proposed the appointment of a new Secretarial Auditor and the continuity of its Executive Chairman, Managing Director, and an Independent Director, all subject to shareholder approval.

To support future initiatives, the authorized share capital will increase from Rs. 15 Cr to Rs. 20 Cr, and an ESOP 2025 scheme granting 20 lakh options was approved, both pending shareholder consent.

Additionally, the Chief Financial Officer has resigned, and the Annual General Meeting will be held to seek necessary approvals.